*Audrey Denizot1, María Fernanda Veloz Castillo2, Corrado Calì3, Erik De Schutter1 (1. Okinawa Institute of Science and Technology, Computational Neuroscience Unit, Onna-Son, Japan, 2. Biological and Environmental Science and Engineering Division, King Abdullah University of Science and Technology, Thuwal, Saudi Arabia, 3. Department of Neuroscience, Neuroscience Institute Cavalieri Ottolenghi, University of Turin, Italy)
Session information
Oral
[3O04a1] Glial Mechanisms
Sat. Jul 2, 2022 2:00 PM - 3:00 PM Room 4 (Conference Building B5~7 (Okinawa Convention Center))
Chair: RYUTA KOYAMA (Laboratory of Chemical Pharmacology,Graduate School of Pharmaceutical Sciences,The University of Tokyo)
*Tetsushi Sadakata1, Keizo Takao2, Ryosuke Kaneko3, Takatoshi Iijima4 (1. Education and Research Support CenterGunma University Graduate School of Medicine, 2. Life Science Research Center, University of Toyama, 3. Laboratories for Integrated Biology, Graduate School of Frontier Biosciences, Osaka University, 4. Institute of Innovative Science and Technology, Tokai University)
*Fuminori Tsuruta1, Sarasa Yano2, Natsu Asami3 (1. Faculty of Life and Env Sci, Univ of Tsukuba, Tsukuba, Japan, 2. Grad Sch of Life and Env Sci, Univ of Tsukuba, Tsukuba, Japan, 3. Col of Biol Sci, Sch of Life and Env Sci, Univ of Tsukuba, Japan)
*Teresa Canedo1,2, Ana Isabel Silva1,3, Elva Bonifácio Andrade1, Tiago Oliveira Almeida1,3, António Pombinho1, Ana Filipa Terceiro1,3, João Bettencourt Relvas1,2, Teresa Summavielle1,4 (1. i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal, 2. Faculdade de Medicina da Universidade do Porto (FMUP), Porto, Portugal, 3. Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto, Porto, Portugal, 4. ESS.PP, Escola Superior de Saúde do Politécnico do Porto, Porto, Portugal)